First Actos Bladder Cancer Trial Beginning in Los Angeles
Approximately 3,000 lawsuits have been filed against the pharmaceutical manufacturer Takeda, alleging that their diabetes drug Actos causes bladder cancer. Actos became the biggest-selling diabetes drug in the world after the manufacturers of Avandia paid over $8 billion to settle claims from patients who suffered strokes and heart attacks while using that medication. It seems that as Actos gobbled up market share in the wake of the negative publicity about Avandia, the manufacturers were downplaying or ignoring news about the increased risk of cancer that was being seen among Actos patients. Jack Cooper, the plaintiff in the case currently being heard in California, alleges that Takeda knew of the increased risk of bladder cancer among Actos patients as early as 1999. The failure to adequately warn of these risks once they knew of them is at the heart of the allegations that Mr. Cooper and his attorneys are making in this case. Germany and France both pulled Actos from their country’s pharmaceutical supplies in 2011 after studies showed an increased risk of bladder cancer among patients taking Actos for one or two years or more. Colling Gilbert Wright & Carter are currently representing several individuals who have been diagnosed with bladder cancer after extended periods of taking Actos for diabetes. We are still evaluating potential claims. If you or a loved one has been diagnosed with bladder cancer after taking prescription Actos, call us today for a free evaluation of your potential legal claims, or contact us online at www.thefloridafirm.com .